Watch, video, people are here and spreading negative news because they want to buy it at a lower price because they know that every day this stock will grow until 6 august, https://youtu.be/vfx-jgKeuBo
GREEN.M
Posts (108)
stock. Their estimates ranged between $2.50 to $5.00 per share for the rest of 2020, meaning there could be a little optimism baked into the estimates. However, the overall 53% decline in revenue is a fairly damning outlook. It will be interesting to see how investors react to this downgrade, after enjoying a nearly 1100% rise off of the 52- week lows of $0.20 per share, so we may end up seeing some profit-taking in light of the revenue downgrade.
The big presentation is tomorrow, and tomorrow the market is closed,? so now is the time to buy
The company has been at the frontline in the identification of new and promising product treatment candidates. The primary focus of its candidates has been the central nervous system (CNS) besides taking on immunology product candidates. Some of the vaccines in the latter category include those which prevent infectious, autoimmune, and cancer diseases while the CNS portfolio includes vaccines for serious psychiatric, pain, and addiction conditions.
The company is hopeful of promising data from animal studies of TNX-1800 before the end of the year. This is a lead vaccine candidate and primarily a live replicating vaccine based on the horsepox viral vector platform.
Weak hands will sell, but don’t worry ? this rocket is going UP UP UP
Load now because after the news will come out it will be to late
Load now, after the news it will be late